Product Description

Opicapone, with the Chemical Abstracts Service (CAS) registry number 923287-50-7, is a pharmacological compound used in the treatment of Parkinson’s disease. Here is a description of Opicapone:

Chemical Structure: Opicapone(CAS 923287-50-7) is a synthetic compound with a relatively simple chemical structure. It belongs to a class of drugs known as COMT (catechol-O-methyltransferase) inhibitors. Its chemical structure includes carbon, hydrogen, oxygen, and nitrogen atoms arranged in a specific pattern.

Pharmacological Significance: Opicapone(CAS 923287-50-7) is primarily used in the management of Parkinson’s disease, a neurodegenerative disorder characterized by the loss of dopamine-producing cells in the brain. Dopamine is a neurotransmitter that plays a crucial role in motor control and coordination.

Mechanism of Action: Opicapone(CAS 923287-50-7) works by inhibiting the enzyme COMT, which is responsible for the breakdown of dopamine in the body. By inhibiting COMT, Opicapone helps to increase and prolong the availability of dopamine in the brain, which can improve motor function and reduce the motor symptoms of Parkinson’s disease.

Use in Combination Therapy: Opicapone is often used in combination with other medications commonly prescribed for Parkinson’s disease, such as levodopa. Levodopa is a precursor to dopamine and is a standard treatment for managing the motor symptoms of Parkinson’s disease. Opicapone extends the duration of action of levodopa, which can lead to smoother and more consistent symptom control.

Clinical Application: Opicapone is typically taken orally in the form of tablets. It is a once-daily medication that can help reduce the number of daily doses of levodopa required to manage Parkinson’s symptoms, which may lead to improved patient adherence and better symptom control.

Dosage and Safety: The dosage of Opicapone can vary depending on the specific needs of the individual and their response to treatment. The medication’s safety and potential side effects would be monitored closely by healthcare professionals during its use, and they may make adjustments as necessary.

In summary, Opicapone is a medication used in the treatment of Parkinson’s disease. Its primary function is to inhibit the COMT enzyme, which helps to prolong the effects of dopamine and improve motor control in individuals with Parkinson’s disease. Opicapone is typically used in combination with other Parkinson’s medications, and its dosage and administration are determined by healthcare professionals based on the individual patient’s needs.